LES BEIGES description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

LES BEIGES

CHANEL PARFUMS BEAUTE

LES BEIGES HEALTHY GLOW SHEER COLOUR, BROAD SPECTRUM SPF 15 SUNSCREEN


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Drug Facts

Active ingredient

Purpose

Active ingredients Purpose
Octinoxate 7% Sunscreen
Titanium dioxide 8% Sunscreen

LES BEIGES Uses

  • helps prevent sunburn
  • if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun.

Warnings

For external use only.

Do not use on damaged or broken skin.

When using this product keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if skin rash occurs.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • For sunscreen use:
    • apply liberally 15 minutes before sun exposure
    • use a water resistant sunscreen if swimming or sweating
    • reapply at least every 2 hours
  • Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
    • limit time in the sun, especially from 10 a.m. – 2 p.m.
    • wear long-sleeved shirts, pants, hats, and sunglasses
    • Children under 6 months of age: Ask a doctor

LES BEIGES Other information

Protect the product in this container from excessive heat and direct sun.

Inactive ingredients

talc • nylon-12 • boron nitride • polyethylene • silica • stearic acid • aluminum dimyristate • alumina • potassium sorbate • butyrospermum parkii (shea) butter • fragrance • sodium dehydroacetate • chlorphenesin • tocopheryl acetate • magnesium myristate • tin oxide • gossypium arboreum (cotton) leaf cell extract • rosa alba leaf cell extract • BHT • citric acid (may contain) ultramarines • iron oxides • titanium dioxide • mica

Questions or comments?

Call 1-800-550-0005 M – F 10am –8pm, S – S 12pm – 6pm EST.

PRINCIPAL DISPLAY PANEL - 12 g Case Carton - N 10

LES BEIGES

HEALTHY GLOW SHEER COLOUR

BROAD SPECTRUM SPF 15 SUNCREEEN

NO 10

CHANEL

POIDS NET 12 g
NET WT. 0.42 OZ.

LES BEIGES

PRINCIPAL DISPLAY PANEL - 12 g Case Carton - N 20

LES BEIGES

HEALTHY GLOW SHEER COLOUR

BROAD SPECTRUM SPF 15 SUNCREEEN

NO 20

CHANEL

POIDS NET 12 g
NET WT. 0.42 OZ.

LES BEIGES

PRINCIPAL DISPLAY PANEL - 12 g Case Carton - N 30

LES BEIGES

HEALTHY GLOW SHEER COLOUR

BROAD SPECTRUM SPF 15 SUNCREEEN

NO 30

CHANEL

POIDS NET 12 g
NET WT. 0.42 OZ.

LES BEIGES

PRINCIPAL DISPLAY PANEL - 12 g Case Carton - N 40

LES BEIGES

HEALTHY GLOW SHEER COLOUR

BROAD SPECTRUM SPF 15 SUNCREEEN

NO 40

CHANEL

POIDS NET 12 g
NET WT. 0.42 OZ.

LES BEIGES

PRINCIPAL DISPLAY PANEL - 12 g Case Carton - N 50

LES BEIGES

HEALTHY GLOW SHEER COLOUR

BROAD SPECTRUM SPF 15 SUNCREEEN

NO 50

CHANEL

POIDS NET 12 g
NET WT. 0.42 OZ.

LES BEIGES

PRINCIPAL DISPLAY PANEL - 12 g Case Carton - N 60

LES BEIGES

HEALTHY GLOW SHEER COLOUR

BROAD SPECTRUM SPF 15 SUNCREEEN

NO 60

CHANEL

POIDS NET 12 g
NET WT. 0.42 OZ.

LES BEIGES

PRINCIPAL DISPLAY PANEL - 12 g Case Carton - N 70

LES BEIGES

HEALTHY GLOW SHEER COLOUR

BROAD SPECTRUM SPF 15 SUNCREEEN

NO 70

CHANEL

POIDS NET 12 g
NET WT. 0.42 OZ.

LES BEIGES

LES BEIGES

OCTINOXATE and TITANIUM DIOXIDE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:68745-2016
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.84 g
titanium dioxide 0.96 g

Inactive Ingredients

Ingredient Name Strength
talc
NYLON-12
BORON NITRIDE
HIGH DENSITY POLYETHYLENE
SILICON DIOXIDE
STEARIC ACID
ALUMINUM DIMYRISTATE
ALUMINUM OXIDE
POTASSIUM SORBATE
SHEA BUTTER
SODIUM DEHYDROACETATE
CHLORPHENESIN
.ALPHA.-TOCOPHEROL ACETATE
MAGNESIUM MYRISTATE
STANNIC OXIDE
BUTYLATED HYDROXYTOLUENE
CITRIC ACID MONOHYDRATE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 CASE
2 0.8 in 1 CASE
3 NDC:68745-2016-3 5 in 1 TRAY

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-08-30


LES BEIGES

OCTINOXATE and TITANIUM DIOXIDE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:68745-2017
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.84 g
titanium dioxide 0.96 g

Inactive Ingredients

Ingredient Name Strength
talc
NYLON-12
BORON NITRIDE
HIGH DENSITY POLYETHYLENE
SILICON DIOXIDE
STEARIC ACID
ALUMINUM DIMYRISTATE
ALUMINUM OXIDE
POTASSIUM SORBATE
SHEA BUTTER
SODIUM DEHYDROACETATE
CHLORPHENESIN
.ALPHA.-TOCOPHEROL ACETATE
MAGNESIUM MYRISTATE
STANNIC OXIDE
BUTYLATED HYDROXYTOLUENE
CITRIC ACID MONOHYDRATE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 CASE
2 0.8 in 1 CASE
3 NDC:68745-2017-3 5 in 1 TRAY

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-08-30


LES BEIGES

OCTINOXATE and TITANIUM DIOXIDE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:68745-2018
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.84 g
titanium dioxide 0.96 g

Inactive Ingredients

Ingredient Name Strength
talc
NYLON-12
BORON NITRIDE
HIGH DENSITY POLYETHYLENE
SILICON DIOXIDE
STEARIC ACID
ALUMINUM DIMYRISTATE
ALUMINUM OXIDE
POTASSIUM SORBATE
SHEA BUTTER
SODIUM DEHYDROACETATE
CHLORPHENESIN
.ALPHA.-TOCOPHEROL ACETATE
MAGNESIUM MYRISTATE
STANNIC OXIDE
BUTYLATED HYDROXYTOLUENE
CITRIC ACID MONOHYDRATE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 CASE
2 0.8 in 1 CASE
3 NDC:68745-2018-3 5 in 1 TRAY

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-08-30


LES BEIGES

OCTINOXATE and TITANIUM DIOXIDE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:68745-2019
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.84 g
titanium dioxide 0.96 g

Inactive Ingredients

Ingredient Name Strength
talc
NYLON-12
BORON NITRIDE
HIGH DENSITY POLYETHYLENE
SILICON DIOXIDE
STEARIC ACID
ALUMINUM DIMYRISTATE
ALUMINUM OXIDE
POTASSIUM SORBATE
SHEA BUTTER
SODIUM DEHYDROACETATE
CHLORPHENESIN
.ALPHA.-TOCOPHEROL ACETATE
MAGNESIUM MYRISTATE
STANNIC OXIDE
BUTYLATED HYDROXYTOLUENE
CITRIC ACID MONOHYDRATE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 CASE
2 0.8 in 1 CASE
3 NDC:68745-2019-3 5 in 1 TRAY

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-08-30


LES BEIGES

OCTINOXATE and TITANIUM DIOXIDE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:68745-2020
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.84 g
titanium dioxide 0.96 g

Inactive Ingredients

Ingredient Name Strength
talc
NYLON-12
BORON NITRIDE
HIGH DENSITY POLYETHYLENE
SILICON DIOXIDE
STEARIC ACID
ALUMINUM DIMYRISTATE
ALUMINUM OXIDE
POTASSIUM SORBATE
SHEA BUTTER
SODIUM DEHYDROACETATE
CHLORPHENESIN
.ALPHA.-TOCOPHEROL ACETATE
MAGNESIUM MYRISTATE
STANNIC OXIDE
BUTYLATED HYDROXYTOLUENE
CITRIC ACID MONOHYDRATE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 CASE
2 0.8 in 1 CASE
3 NDC:68745-2020-3 5 in 1 TRAY

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-08-30


LES BEIGES

OCTINOXATE and TITANIUM DIOXIDE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:68745-2021
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.84 g
titanium dioxide 0.96 g

Inactive Ingredients

Ingredient Name Strength
talc
NYLON-12
BORON NITRIDE
HIGH DENSITY POLYETHYLENE
SILICON DIOXIDE
STEARIC ACID
ALUMINUM DIMYRISTATE
ALUMINUM OXIDE
POTASSIUM SORBATE
SHEA BUTTER
SODIUM DEHYDROACETATE
CHLORPHENESIN
.ALPHA.-TOCOPHEROL ACETATE
MAGNESIUM MYRISTATE
STANNIC OXIDE
BUTYLATED HYDROXYTOLUENE
CITRIC ACID MONOHYDRATE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 CASE
2 0.8 in 1 CASE
3 NDC:68745-2021-3 5 in 1 TRAY

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-08-30


LES BEIGES

OCTINOXATE and TITANIUM DIOXIDE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:68745-2022
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.84 g
titanium dioxide 0.96 g

Inactive Ingredients

Ingredient Name Strength
talc
NYLON-12
BORON NITRIDE
HIGH DENSITY POLYETHYLENE
SILICON DIOXIDE
STEARIC ACID
ALUMINUM DIMYRISTATE
ALUMINUM OXIDE
POTASSIUM SORBATE
SHEA BUTTER
SODIUM DEHYDROACETATE
CHLORPHENESIN
.ALPHA.-TOCOPHEROL ACETATE
MAGNESIUM MYRISTATE
STANNIC OXIDE
BUTYLATED HYDROXYTOLUENE
CITRIC ACID MONOHYDRATE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 12 in 1 CASE
2 0.8 in 1 CASE
3 NDC:68745-2022-3 5 in 1 TRAY

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-08-30


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.